Goldman Sachs’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.5M | Sell |
3,182,619
-107,275
| -3% | -$2.61M | 0.01% | 902 |
|
|
2025
Q1 | $68.3M | Sell |
3,289,894
-337,052
| -9% | -$7M | 0.01% | 880 |
|
|
2024
Q4 | $85.4M | Buy |
3,626,946
+1,815,638
| +100% | +$42.7M | 0.01% | 749 |
|
|
2024
Q3 | $46.4M | Buy |
1,811,308
+904,573
| +100% | +$23.2M | 0.01% | 1114 |
|
|
2024
Q2 | $21.3M | Buy |
906,735
+560,674
| +162% | +$13.2M | ﹤0.01% | 1564 |
|
|
2024
Q1 | $9.95M | Sell |
346,061
-296,739
| -46% | -$8.53M | ﹤0.01% | 2050 |
|
|
2023
Q4 | $21.1M | Buy |
642,800
+469,740
| +271% | +$15.4M | ﹤0.01% | 1504 |
|
|
2023
Q3 | $4.82M | Buy |
173,060
+48,023
| +38% | +$1.34M | ﹤0.01% | 2490 |
|
|
2023
Q2 | $4.26M | Sell |
125,037
-785,711
| -86% | -$26.8M | ﹤0.01% | 2678 |
|
|
2023
Q1 | $27.4M | Buy |
910,748
+238,636
| +36% | +$7.18M | 0.01% | 1287 |
|
|
2022
Q4 | $19M | Sell |
672,112
-675,515
| -50% | -$19.1M | ﹤0.01% | 1674 |
|
|
2022
Q3 | $44.3M | Buy |
1,347,627
+694,636
| +106% | +$22.8M | 0.01% | 1039 |
|
|
2022
Q2 | $20.6M | Sell |
652,991
-1,181,680
| -64% | -$37.2M | 0.01% | 1589 |
|
|
2022
Q1 | $84.3M | Buy |
1,834,671
+1,172,438
| +177% | +$53.8M | 0.02% | 749 |
|
|
2021
Q4 | $40.6M | Buy |
662,233
+489,624
| +284% | +$30M | 0.01% | 1276 |
|
|
2021
Q3 | $12.9M | Sell |
172,609
-582,869
| -77% | -$43.6M | ﹤0.01% | 2059 |
|
|
2021
Q2 | $69.9M | Buy |
755,478
+396,398
| +110% | +$36.7M | 0.02% | 854 |
|
|
2021
Q1 | $31.9M | Buy |
359,080
+353,502
| +6,337% | +$31.4M | 0.01% | 1335 |
|
|
2020
Q4 | $520K | Buy |
+5,578
| New | +$520K | ﹤0.01% | 3804 |
|